This grant funds multidisciplinary teams to research rare melanomas, requiring collaboration among 2-3 projects, inclusion of a survivor or advocate, and offers up to $2.8M per award over 4 years.
Funder: Dept. of the Army -- USAMRAA
Due Dates: July 13, 2026: Pre-Application | October 14, 2026: Full Application | October 20, 2026: Application Verification Deadline
Funding Amounts: ~$5.6M total; up to $2.8M per award (4 years); ~2 awards expected
Summary: Supports multidisciplinary research programs addressing critical unmet needs in rare melanomas, requiring collaboration among at least two principal investigators and a rare melanoma survivor or patient advocate.
Key Information: Invitation required for full application; clinical trials allowed; rare melanoma consumer collaboration is mandatory.
This opportunity supports multidisciplinary research programs focused on rare melanomas through the Department of Defense's Melanoma Research Program (MRP). Each application must address a critical unmet need in rare melanoma research or patient care by integrating at least two, but not more than three, distinct yet complementary research projects under a unifying overarching question. A unique feature is the required involvement of a rare melanoma survivor or patient advocate as a collaborator throughout the project. The mechanism is designed for collaborative teams with an Initiating Principal Investigator (PI) and at least one (up to two) Partnering PIs, each leading a research project. Clinical trials are allowed, and the research may span the spectrum from basic biology to clinical intervention and survivorship.